I live in England and so far have been treated on the NHS. I was diagnosed 3 years ago at the age of 70 and apart from the cancer I am generally quite fit and play golf, go walking and enjoy gardening. Apart from some occasional tenderness when sitting down I am lucky not to have any pain. I am once again at a treatment crossroads, so any ideas or insights are welcome. I do not have any issues with the treatment I have received so far but have not ruled out a private consultation if there appear to be worthwhile treatments unavailable on the NHS.
March 2022 Biopsy & CT Scan, PSA 154 , Gleason 4+5 = 9, widespread bone metastases - Spine -L2, T7, rt.acetabulum, rt.ischium, pubic ramus & sacrum; lymphadenopathy but no visceral disease.
Hormone therapy is the backbone of treatment - initially 10 weeks bicalutamide, then quarterly Prostap ( Leuprorelin ) injections for life. PSA down to 40 after end of bicalutamide tablets.
Started Docetaxel ( Taxotere ) with prednisolone in late June 2022, 6 cycles to October 2022 when stopped both; PSA down to 0.6, and continued to decline for another 6 months when got to its lowest at 0.3.
PSA started rising again by August 2023; CT & Nuclear Medical bone scans showed no disease progression then, and lymph nodes had shrunk, but a further CT scan in December 2023 showed a new lesion in pubic bone and some soft tissue thickening.
By end January 2024 PSA was up to 38, and started Abiraterone ( Zytiga ) with prednisolone.The lowest that PSA came down to was 8.2 I stayed on abiraterone for 8 months until PSA started rising again, but kept taking prednisolone. CT & NM scans in August 2024 showed some additional pelvic tumours and one under left armpit.
Started Cabazitaxel ( Jevtana ) ( 75% dose ) with prednisolone in October 2024 and have recently completed 8 cycles. Lowest PSA got down to was 16.5 in December 2024, and PSA now up to 34. Cabazitaxel stopped but now taking daily dexamethazone steroid instead of prednisolone.
( A BRCA test on the prostate samples was negative, so Olaparib was not an option ).
My Oncologist is looking at what clinical trials may be available for me, and has also said that I could have Radium 223 ( Xofigo ) if I started getting bone pain.
Some specific questions I have:-
I have been told that you either have Abiraterone ( Jevtana ) or Enzalutamide ( Xtandi ). I am not clear if this is because if one drug stops working then the other is unlikely to work, or whether it is an NHS funding issue. Does anyone know, or has anyone had enzalutamide after abiraterone ?
Having just reviewed my treatment history, docetaxel seems to have been the most effective, but this may just have been because it was one of the early ones. Is re-treatment with docetaxel a viable option?
I like the idea of a radioligand treatment which targets cancer cells rather than healthy cells and I wonder why radium 223 ( Xofigo ) is only offered if you have pain - if it is effective then why not use it ? - perhaps an NHS funding issue. ( Having seen some of the posts on this website about Lutetium 177 ( Pluvicto ), I am not sure that that would be a good option for me ).
Many thanks in advance to anyone who takes the time to read all this and reply!